Expert Opinion on Therapeutic Targets

Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets
pp. 1137-1145(9)
Authors: Adams, Heiner; Campidelli, Cristina; Dirnhofer, Stephan; Pileri, Stefano A; Tzankov, Alexandar

Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus
pp. 1147-1153(7)
Authors: Chong, Benjamin F; Mohan, Chandra

Targeting the JAK2/STAT3 axis in Alzheimer's disease
pp. 1155-1167(13)
Authors: Chiba, Tomohiro; Yamada, Marina; Aiso, Sadakazu

TrkB as a therapeutic target for ovarian cancer
pp. 1169-1178(10)
Authors: Siu, Michelle KY; Wong, Oscar GW; Cheung, Annie NY

Targeting the IGF1 axis in cancer proliferation
pp. 1179-1192(14)
Authors: Bruchim, Ilan; Attias, Zohar; Werner, Haim

Enhancing mTOR-targeted cancer therapy
pp. 1193-1203(11)
Authors: Wang, Xuerong; Sun, Shi-Yong

Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
pp. 1205-1226(22)
Authors: Pasquali, Renato; Gambineri, Alessandra

Targeting microRNAs in obesity
pp. 1227-1238(12)
Authors: Xie, Huangming; Sun, Lei; Lodish, Harvey F

RPGR and RP2: targets for the treatment of X-linked retinitis pigmentosa?
pp. 1239-1251(13)
Authors: Veltel, Stefan; Wittinghofer, Alfred